Acute Myeloid Leukemia: Examining the Pharmacologic Profiles and Integration of Treatment Advances

Earn CME for related activities: https://www.naccme.com/oln

Featuring a presentation by Dr. Christopher A. Fausel, this on-demand webcast examines novel chemotherapeutic formulations and targeted agents in the treatment of AML in terms of clinical outcomes, pharmacologic profiles, reduced toxicity, and pharmacoeconomic data.

© 2018 NACCME, an HMP Company